Data spotlight: Sale of Vantage Oncology leads VC-backed M&A in April

Seven of the April acquisitions disclosed financials terms, which combined to about $3.3 billion in value

17 May 2016•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail